 |
|
|
| |
Variables Associated With Neuropsychiatric Symptoms in PLWH Receiving Dolutegravir-Based Therapy in Phase III Clinical Trials
|
| |
| |
Reported by Jules Levin
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
Jean van Wyk,1James Oyee,2Sophie Barthel,2Justin Koteff,3Brian Wynne,3Lloyd Curtis,2Vani Vannappagari,3Nassrin Payvandi,1Val Carr,1Tia Vincent,1Michael Aboud1
1ViiV Healthcare, Brentford, UK; 2GlaxoSmithKline, Stockley Park, UK; 3ViiV Healthcare, Research Triangle Park, NC, USA
|
| |
|
|
|
|
|
